Portal:Drug Metabolism/AllPathways

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Current revision (09:12, 17 April 2015) (view source)
(Mode of Action)
 
(16 intermediate revisions not shown.)
Line 1: Line 1:
 +
== Mode of Action ==
 +
 +
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
 +
 +
* [[Pathway:WP339|dorsomorphin]]
 +
* [[Pathway:WP1601|fluoropyrimidine]]
 +
* nicotine ([[Pathway:WP1603|chromaffin cells]] and [[Pathway:WP1602|dopaminergic neurons]])
 +
* [[Pathway:WP259|nifedipine]]
 +
 +
</div>
 +
 +
== Biotransformations ==
 +
 +
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
 +
 +
* [[Pathway:WP2712|abacavir]]
* [[Pathway:WP2640|aripiprazole]]
* [[Pathway:WP2640|aripiprazole]]
 +
* [[Pathway:WP2826|cocaine]]
 +
* [[Pathway:WP1604|codeine]]
* [[Pathway:WP2536|colchicine]]
* [[Pathway:WP2536|colchicine]]
* [[Pathway:WP2561|dantrolene]]
* [[Pathway:WP2561|dantrolene]]
* [[Pathway:WP2491|diclofenac]]
* [[Pathway:WP2491|diclofenac]]
 +
* [[Pathway:WP2816|felbamate]]
 +
* [[Pathway:WP2645|heroin]]
 +
* [[Pathway:WP2646|lidocaine]]
* [[Pathway:WP2540|methapyrilene]]
* [[Pathway:WP2540|methapyrilene]]
 +
* [[Pathway:WP1604|morphine]]
* [[Pathway:WP2537|moxicylyte]]
* [[Pathway:WP2537|moxicylyte]]
-
* sulindac ([[Pathway:WP2541|rat]] [[Pathway:WP2542|human]])
+
* [[Pathway:WP1600|nicotine]]
 +
* sulindac ([[Pathway:WP2541|rat]] and [[Pathway:WP2542|human]])
* [[Pathway:WP691|tamoxifen]]
* [[Pathway:WP691|tamoxifen]]
 +
 +
</div>
 +
 +
== Receptor binding ==
 +
 +
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
 +
 +
* [[Pathway:WP455|bradykinin]]
 +
* [[Pathway:WP455|dopamine]]
 +
* [[Pathway:WP455|histamine]]
 +
* [[Pathway:WP455|melatonin]]
 +
* [[Pathway:WP455|prostaglandin]]
 +
* [[Pathway:WP455|serotonin]]
 +
 +
</div>

Current revision

Mode of Action

Biotransformations

Receptor binding